Abstract
A comprehensive and collaborative strategy to enable the investigation of new uses of approved and abandoned drug compounds could advance translational research.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Journal of Experimental & Clinical Cancer Research Open Access 23 January 2024
-
Drug repurposing: a systematic review on root causes, barriers and facilitators
BMC Health Services Research Open Access 29 July 2022
-
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
Nature Communications Open Access 23 September 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–214 (2010).
US FDA. http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions /HowtoapplyforOrphanProductDesignation/ucm216147.htm (2010).
Huang, R. et al. The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics Sci. Transl. Med. 3, 80ps16 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Collins, F. Mining for therapeutic gold. Nat Rev Drug Discov 10, 397 (2011). https://doi.org/10.1038/nrd3461
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd3461
This article is cited by
-
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
Journal of Experimental & Clinical Cancer Research (2024)
-
Drug repurposing: a systematic review on root causes, barriers and facilitators
BMC Health Services Research (2022)
-
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
Nature Communications (2020)
-
Suppression of glioblastoma by a drug cocktail reprogramming tumor cells into neuronal like cells
Scientific Reports (2019)
-
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Nature (2017)